Microfluidics Market

Danaher Corporation (US), Thermo Fisher Scientific (US) and Bio-Rad Laboratories (US) are leading players in Microfluidics Market

The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period. The microfluidics industry is booming with the presence of regional and multinational market players. Danaher Corporation (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), and F. Hoffmann-La Roche (Switzerland) are some of the leading players in the microfluidics market.

The key players in this market are focusing on increasing their presence with the adoption of both organic and inorganic growth strategies. These include product approvals, launches, agreements, partnerships, collaborations, expansions, and acquisitions.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US) was the leading player in the microfluidics market. Danaher is a science and technology innovator, with a global family of more than 20 operating sub-companies. Of all the companies under Danaher Corporation, Cepheid (US), Beckman Coulter, Inc. (US), AB Sciex LLC (US), and Molecular Devices, LLC (US) are currently engaged in providing solutions for the market. The company has strategically enhanced its presence in the global microfluidics market by pursuing several inorganic and organic growth strategies, such as collaborations. In February 2020, Cepheid announced a research collaboration with Sherlock Biosciences (US) to explore the development of new cutting-edge molecular diagnostic tests for COVID-19. They are combining Sherlock BiosciencesSHERLOCK, a CRISPR-based technology (that can identify virtually any genetic target) with Cepheids GeneXpert Systems. The company has facilities in over 60 countries, which include 336 major manufacturing and distribution facilities; 160 of the total facilities are located in the US in over 25 states, and 176 are located outside the US in over 30 other countries (primarily in Europe and to a lesser extent in Asia and the rest of North America, South America, and Australia).

Thermo Fisher Scientific (US) is a global player in the microfluidics market, with wide geographic coverage. The company has maintained its leading position in the market through strong distribution networks across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In addition, it has five well-established brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company emphasizes on developing and introducing new and improved products through continued R&D activities. The company focuses on strategic collaborations to come up with enhanced solutions and strengthen its product portfolio in the microfluidics market. In March 2020, the company announced that the board of directors and managing boards of QIAGEN approved Thermo Fisher’s proposal to acquire QIAGEN. This acquisition is expected to broaden Thermo Fisher’s specialty diagnostics product portfolio and increase its share in the overall IVD market, including the POC diagnostics and microfluidics sectors.

Bio-Rad Laboratories (US) is a key competitor in the microfluidics market. The company has a global network of operations that serves life sciences research and clinical diagnostic customers. The company also has an extensive geographic presence with direct distribution channels in more than 30 countries. This enables it to maintain a strong customer base. Bio-Rad has manufacturing and R&D facilities in the US, France, China, Germany, Singapore, Belgium, and Switzerland. The company focuses on strategic acquisitions to strengthen its presence in the microfluidics market. It also aims at introducing technologically advanced products to cater to the changing customer needs. In 2017, Bio-Rad acquired RainDance Technologies (US), a developer of microfluidic-based PCR systems. This enabled Bio-Rad to offer technologically advanced products to its customers and strengthen its existing portfolio.

Related Reports:

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
AST 7541
RI Published ON
5/14/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Microfluidics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved